Early Value Definition: A paradigm shift
Publication

February 20, 2017

Early Value Definition: A paradigm shift

Early Market Access assessment for diagnostics in personalized medicine
Publication

February 07, 2017

Early Market Access assessment for diagnostics in personalized medicine

How to tailor your global market access strategy to local needs
Publication

December 13, 2016

How to tailor your global market access strategy to local needs

The future of innovative contracting in pharma
Publication

November 23, 2016

The future of innovative contracting in pharma

Achieving patient centricity: 4 key lessons from orphan disease companies
Publication

October 11, 2016

Achieving patient centricity: 4 key lessons from orphan disease companies

Orphan drugs – leading the way in patient centricity
Publication

October 10, 2016

Orphan drugs – leading the way in patient centricity

Recorded Webinar: How to strengthen Market Access
Publication

October 03, 2016

Recorded Webinar: How to strengthen Market Access

Strengthening market access deliverables by harnessing the patient journey
Publication

September 27, 2016

Strengthening market access deliverables by harnessing the patient journey

Biopharma without borders - commercial model for niche specialty care and orphan products
Publication

September 15, 2016

Biopharma without borders - commercial model for niche specialty care and orphan products

The case for Market Access leadership in brand team integration
Publication

May 31, 2016

The case for Market Access leadership in brand team integration

Medical Affairs- The time for change is now
Publication

May 09, 2016

Medical Affairs- The time for change is now

Current perspectives on the biopharma go-to-market model
Publication

January 04, 2016

Current perspectives on the biopharma go-to-market model